Merck Entrance on Lansdale, PA

FDA Panel OKs First COVID Pill 'Molnupiravir' From Merck

FDA panel "narrowly' backs Merck's COVID pill known as molnupiravir.
Pfizer’s COVID Pill Cuts 89 Percent of Severe COVID Cases: Clinical Trial Results

Pfizer's COVID Pill Cuts 89 Percent of Severe COVID Cases: Clinical Trial Results

By Mary Webber
U.S. pharmaceutical company Pfizer has developed a COVID pill noting that it reduces the risk of severe COVID cases by 89 percent, according to the clinical trials of the company.
Most Read
  1. Jennifer Lopez Returned to The Music Stage
  2. Ángela Aguilar Booed at the Kids Choice Awards
  3. Maite Perroni's Relationship with Anahí & Dulce María Is Seemingly Strained
  4. Natasha Dupeyrón Faces Harsh Backlash After Defending Ángela Aguilar
  5. Xavi Confirms That He Has A Son: "We Had Nothing" - VIDEO
Real Time Analytics